Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Alzheimer's Disease

Free Subscription 01.12.2025 1 Acta Neuropathol 5 Alzheimer Dis Assoc Disord 15 Alzheimers Dement 1 Am J Geriatr Psychiatry 2 BMC Neurol 2 Brain 1 Brain Res 1 Exp Gerontol 10 J Alzheimers Dis 2 J Biol Chem 1 J Neurochem 3 Nat Neurosci 1 Nat Rev Neurol 1 Neurochem Res 2 Neurology 1 Neurosci Lett

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. IOANNOU K, Perrin RJ, Abdullaieva K, Bluma M, et al
   Neuropathologic correlates of cognitive impairment in Alzheimer's disease with discordant CSF biomarker profiles: co-pathologies in focus.
   Acta Neuropathol. 2025;150:57.
   PubMed         Abstract available
   
   

   
   Alzheimer Dis Assoc Disord

2. HOULIHAN H, Guzman D, Smith A, Sanchez T, et al
   Neuroimaging Compendium of Microglia, Amyloid, Tau, and Neurodegeneration Across Clinical Variants of Alzheimer Disease.
   Alzheimer Dis Assoc Disord. 2025;39:315-319.
   PubMed         Abstract available
   
   
3. DIAZ D, Kirk A, O'Connell M, Morgan D, et al
   Do Education and Premorbid Intelligence Predict Cognitive Decline Over 1 Year in Rural Patients with Dementia?
   Alzheimer Dis Assoc Disord. 2025;39:307-312.
   PubMed         Abstract available
   
   
4. SMITH A, Guzman D, Lee S, Talmasov D, et al
   Inflammatory Alterations and Multidomain Cognition in Alzheimer Disease and Related Dementias.
   Alzheimer Dis Assoc Disord. 2025;39:181-190.
   PubMed         Abstract available
   
   
5. GRAFF RE, Chen DM, Swinnerton KN, Ackley SF, et al
   Evaluation of Polygenic Risk Scores for a Possible Genetic Basis of the Inverse Association Between Cancer and Cognitive Decline.
   Alzheimer Dis Assoc Disord. 2025;39:235-243.
   PubMed         Abstract available
   
   
6. TAN A, Wang Z, Aumont E, Li A, et al
   Determinants of Treatment Willingness and Willingness-to-Pay for Lecanemab in China: A Network Analysis.
   Alzheimer Dis Assoc Disord. 2025;39:223-230.
   PubMed         Abstract available
   
   

   
   Alzheimers Dement

7. BOLTON CJ, Zhang P, Wilhoite SR, Moore EE, et al
   Increased neuroplastic activity in the pathogenesis of Alzheimer's disease.
   Alzheimers Dement. 2025;21:e70897.
   PubMed         Abstract available
   
   
8. MANGALMURTI A, Zengeler KE, Hollis A, Golden E, et al
   Microglial CLEC7A restrains amyloid beta plaque pathology in a mouse model of Alzheimer's disease.
   Alzheimers Dement. 2025;21:e70943.
   PubMed         Abstract available
   
   
9. BANIHASHEMI MA, Krance SH, Ji PX, Koo M, et al
   Brain and retina in Alzheimer's disease: Pathological intersections and estimates from imaging.
   Alzheimers Dement. 2025;21:e70884.
   PubMed         Abstract available
   
   
10. GUGLIELMO S, Di Nardo N, Scantamburlo M, Mainardi M, et al
    Chemogenetic manipulation of learning-tagged neurons is sufficient to rescue progressive memory deficits in a mouse model of Alzheimer's disease.
    Alzheimers Dement. 2025;21:e70953.
    PubMed         Abstract available
    
    
11. XU Y, Qiao M, Gunasekaran TI, Gu Y, et al
    Polygenic scores of Core 1 Alzheimer's disease biomarkers predict early cognitive and pathological change.
    Alzheimers Dement. 2025;21:e70937.
    PubMed         Abstract available
    
    
12. LA JOIE R, Cummings JL, Dage JL, Galasko D, et al
    Treatment-related amyloid clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapies.
    Alzheimers Dement. 2025;21:e70997.
    PubMed         Abstract available
    
    
13. LI Y, Liu W, Wang X, Qin W, et al
    Effect of SSRIs on clinical progression in amnestic mild cognitive impairment stratified by Alzheimer's disease pathology.
    Alzheimers Dement. 2025;21:e70946.
    PubMed         Abstract available
    
    
14. MENTA BW, Schueddig E, Ranjan A, Li Y, et al
    MtDNA-depleted neuronal cell transcriptomes reveal Alzheimer's disease-related changes.
    Alzheimers Dement. 2025;21:e70929.
    PubMed         Abstract available
    
    
15. TU YY, Cui L, Zhang Z, Wang M, et al
    Subjective sleep characteristics in non-demented adults: domain-specific associations with multimodal Alzheimer's disease biomarkers.
    Alzheimers Dement. 2025;21:e70932.
    PubMed         Abstract available
    
    
16. HUMBLET-BARON S, Feng Y, Veiga R, Neumann J, et al
    A systems immunology analysis of Alzheimer's disease reveals an age- and environmental exposure-independent disturbance in B cell maturation.
    Alzheimers Dement. 2025;21:e70952.
    PubMed         Abstract available
    
    
17. UM YH, Wynveen P, Holland M, Bhatt K, et al
    Neuroimaging correlates and biomarker performance of a fully automated plasma p-tau217/Abeta42 ratio assay in a clinical cohort with Alzheimer's disease.
    Alzheimers Dement. 2025;21:e70942.
    PubMed         Abstract available
    
    
18. BALOGUN WG, Zeng X, Triana-Baltzer G, Saeed A, et al
    Cross-cohort validation and cutpoint estimation of the Janssen plasma p-tau217+ assay in predominantly cognitively normal community studies.
    Alzheimers Dement. 2025;21:e70916.
    PubMed         Abstract available
    
    
19. INTZANDT B, Ramirez J, Lam B, Masellis M, et al
    Exploring sex-specific risk factors in cognitive decline: Insights into modifiable and non-modifiable determinants using a network analysis.
    Alzheimers Dement. 2025;21:e70825.
    PubMed         Abstract available
    
    
20. KANG S, Jeon S, Kim Y, Jeon SH, et al
    Putaminal hypermetabolism identifies Lewy body co-pathology in Alzheimer's disease.
    Alzheimers Dement. 2025;21:e70920.
    PubMed         Abstract available
    
    
21. KUEHN JF, Zhang Q, Heston MB, Kang JW, et al
    Fecal short-chain fatty acids vary by sex and amyloid status.
    Alzheimers Dement. 2025;21:e70877.
    PubMed         Abstract available
    
    

    
    Am J Geriatr Psychiatry

22. ZIDE BS, Gagliardi G, Jacobs HIL, Gatchel JR, et al
    Living Alone, Early Tau Pathology, and Loneliness in Cognitively Unimpaired Older Adults During the COVID-19 Pandemic.
    Am J Geriatr Psychiatry. 2026;34:57-69.
    PubMed         Abstract available
    
    

    
    BMC Neurol

23. WU M, Gao L, Su Q, Wang H, et al
    Global burden, spatiotemporal disparities, and sex-specific trends of early- and late-onset Alzheimer's disease and other dementias: a comparative analysis and projections to 2035.
    BMC Neurol. 2025 Nov 24. doi: 10.1186/s12883-025-04530.
    PubMed         Abstract available
    
    
24. BASTAN F, Saeedi-Moghaddam F, Rashidian M, Mirhosseini F, et al
    Human herpesvirus 6 (HHV-6) infection and risk of Alzheimer's disease: a systematic review and meta-analysis.
    BMC Neurol. 2025 Nov 22. doi: 10.1186/s12883-025-04500.
    PubMed         Abstract available
    
    

    
    Brain

25. KIM B, Yuk M, Park M, Ryu H, et al
    CRISPR editing of miR-33 restores ApoE lipidation and amyloid-beta metabolism in ApoE4 sporadic Alzheimer's disease.
    Brain. 2025 Nov 25:awaf244. doi: 10.1093.
    PubMed         Abstract available
    
    
26. PINI L, Allali G, Imbimbo BP, Germani M, et al
    Brain connectivity as a new target for Alzheimer's disease therapy?
    Brain. 2025 Nov 28:awaf404. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Brain Res

27. HUI S, Long Y, Zhu L, Shi W, et al
    IGF2BP2-mediated m6A modification of IGF1R mRNA promotes neuronal senescence and cognitive decline in Alzheimer's disease.
    Brain Res. 2025;1871:150067.
    PubMed         Abstract available
    
    

    
    Exp Gerontol

28. CHEN PH, Lin SI, Liao YY, Hu GC, et al
    Plasma Alzheimer's biomarkers and physical functions in aging adults with and without motoric cognitive risk syndrome.
    Exp Gerontol. 2025;212:112975.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

29. VIADA C, Fors M, Capote E, Santiesteban Y, et al
    Bayesian predictive probability for binary outcomes in neurodegenerative diseases.
    J Alzheimers Dis. 2025;108:1222-1230.
    PubMed         Abstract available
    
    
30. SATO K, Ihara R, Niimi Y, Suzuki K, et al
    Property difference in Mini-Mental State Examination Serial Sevens and World Backwards: Analysis using item response theory.
    J Alzheimers Dis. 2025;108:1015-1022.
    PubMed         Abstract available
    
    
31. D'ANSELMO A, Prete G, Di Crosta A, Bristot L, et al
    Increased pre-alpha functional connectivity in dementia with Lewy bodies.
    J Alzheimers Dis. 2025;108:1132-1143.
    PubMed         Abstract available
    
    
32. WU X, Tsuchiya I, Aung KZ, Qiao Q, et al
    Genetic association analyses of cognitive performance across multi-ancestry older adults: Application of Tobit models.
    J Alzheimers Dis. 2025;108:1312-1327.
    PubMed         Abstract available
    
    
33. 
    Corrigendum to 'Autoantibodies in Alzheimer's disease: Multifaceted roles and therapeutic horizons'.
    J Alzheimers Dis. 2025 Nov 24:13872877251401326. doi: 10.1177/13872877251401326.
    PubMed        
    
    
34. PANZA F, Lozupone M, Resta E, Quarto S, et al
    Gustatory dysfunction and oral frailty: Emerging implications for Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 24:13872877251392552. doi: 10.1177/13872877251392552.
    PubMed         Abstract available
    
    
35. AFRIDI MA, Khalid MM, Din RU
    Multi-modal approaches to Alzheimer's disease diagnosis: Combining cognitive assessments with biomarkers and imaging.
    J Alzheimers Dis. 2025 Nov 24:13872877251394315. doi: 10.1177/13872877251394315.
    PubMed         Abstract available
    
    
36. CHACON T, Hernandez-Hincapie H
    Relationship periodontitis and Alzheimer's disease: Relevant aspects from an epigenetic view.
    J Alzheimers Dis. 2025 Nov 26:13872877251397406. doi: 10.1177/13872877251397406.
    PubMed         Abstract available
    
    
37. USHER MR, Aybar-Torres AA, Jin L
    Identification of common human TMEM173 genotypes associated with Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 27:13872877251396973. doi: 10.1177/13872877251396973.
    PubMed         Abstract available
    
    
38. ZHOU W, Lin H, Huang X, Zhou X, et al
    Identification and validation of PANoptosis-related genes in Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 27:13872877251396927. doi: 10.1177/13872877251396927.
    PubMed         Abstract available
    
    

    
    J Biol Chem

39. ZHANG DY, Wang J, Huang G, Dokholyan M, et al
    Apolipoprotein E (APOE) regulates the transport of monosialotetrahexosylganglioside (GM1).
    J Biol Chem. 2025;301:110778.
    PubMed         Abstract available
    
    
40. LUNDIN B, Wieckiewicz N, Yokomizo M, Sadek M, et al
    APP family is a regulator of endo-lysosomal membrane vulnerability.
    J Biol Chem. 2025;301:110774.
    PubMed         Abstract available
    
    

    
    J Neurochem

41. PEREZ-RAMIREZ R, Cuchillo-Ibanez I, Sanchez-Romero R, Beltran-Sanahuja A, et al
    Development and Validation of an ICP-MS/MS Method for the Multielemental Analysis of Cerebrospinal Fluid, Examination of Alzheimer's Disease Samples.
    J Neurochem. 2025;169:e70307.
    PubMed         Abstract available
    
    

    
    Nat Neurosci

42. JIN M, Ma Z, Dang R, Zhang H, et al
    A myeloid trisomy 21-associated gene variant is protective from Alzheimer's disease.
    Nat Neurosci. 2025 Nov 24. doi: 10.1038/s41593-025-02117.
    PubMed         Abstract available
    
    
43. ALBERTINI G, Zielonka M, Cuypers ML, Snellinx A, et al
    The Alzheimer's therapeutic Lecanemab attenuates Abeta pathology by inducing an amyloid-clearing program in microglia.
    Nat Neurosci. 2025 Nov 24. doi: 10.1038/s41593-025-02125.
    PubMed         Abstract available
    
    
44. CHOI DJ, Murali S, Kwon W, Woo J, et al
    Astrocytic Sox9 overexpression in Alzheimer's disease mouse models promotes Abeta plaque phagocytosis and preserves cognitive function.
    Nat Neurosci. 2025 Nov 21. doi: 10.1038/s41593-025-02115.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

45. BROWN GC, St George-Hyslop P, Paolicelli RC, Lemke G, et al
    Microglial phagocytosis in Alzheimer disease.
    Nat Rev Neurol. 2025 Nov 28. doi: 10.1038/s41582-025-01162.
    PubMed         Abstract available
    
    

    
    Neurochem Res

46. WANG M, Zeng Y, Jin Y, Wu J, et al
    Progress and Perspectives on the Estrogen-Microbiota-Brain Axis in Alzheimer's Disease.
    Neurochem Res. 2025;51:3.
    PubMed         Abstract available
    
    

    
    Neurology

47. FILIPPI M, Cecchetti G
    Choroid Plexus Morphology in Alzheimer Disease: Bridging Pathology and Cognition.
    Neurology. 2025;105:e214017.
    PubMed        
    
    
48. LIN M, Zeng Q, Zhong S, Nie S, et al
    Association Between Choroid Plexus Morphological Alterations, Alzheimer Pathologies, and Cognitive Impairment: A Longitudinal Study.
    Neurology. 2025;105:e213953.
    PubMed         Abstract available
    
    

    
    Neurosci Lett

49. PRATAP GK, Pramoda GN, Joshi CG, Sannegowda LK, et al
    Structure-function characterization of olea dioica PGK-1: Acetylcholinesterase inhibition, molecular docking, and amelioration of Abeta42-induced toxicity in SH-SY5Y neuronal cells and the UAS-Abeta(42); ey-GAL4 drosophila model of Alzheimer's disease
    Neurosci Lett. 2025 Nov 26:138467. doi: 10.1016/j.neulet.2025.138467.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.